5-Fluorouracil loaded magnetic cellulose bionanocomposites for potential colorectal cancer treatment

被引:50
|
作者
Yusefi, Mostafa [1 ]
Lee-Kiun, Michiele Soon [2 ]
Shameli, Kamyar [1 ]
Teow, Sin-Yeang [2 ]
Ali, Roshafima Rasit [1 ]
Siew, Kit-Kim [3 ]
Chan, Hui-Yin [2 ]
Wong, Magdelyn Mei-Theng [2 ]
Lim, Wei-Ling [3 ]
Kuca, Kamil [1 ,4 ]
机构
[1] Univ Teknol Malaysia, Malaysia Japan Int Inst Technol, Jalan Sultan Yahya Petra, Kuala Lumpur 54100, Malaysia
[2] Sunway Univ, Sch Med & Life Sci, Dept Med Sci, Jalan Univ, Bandar Sunway 47500, Selangor Darul, Malaysia
[3] Sunway Univ, Sch Med & Life Sci, Dept Biol Sci, Jalan Bandar Sunway, Selangor Darul Ehsan 47500, Malaysia
[4] Univ Hradec Kralove, Fac Sci, Dept Chem, Hradec Kralove, Czech Republic
关键词
Cellulose; Fe3O4-nanoparticles; Composites; 5-Fluorouracil; Drug carrier system; Colorectal cancer; Microfluidic; Co-culture; TARGETED DRUG-DELIVERY; OXIDE NANOPARTICLES; FIBERS; RICE;
D O I
10.1016/j.carbpol.2021.118523
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Magnetic polymer nanocomposites are inherently multifunctional and harbor assorted physiochemical actions for applications thereof as novel drug nanocarriers. Herein, Fe3O4-nanoparticles were supported on rice straw cellulose for 5-fluorouracil carrier abbreviated as MC/5-FU for potential colorectal cancer treatments. Several analyses indicated the multifunctional properties of MC/5-FU bionanocomposites. Transmission and scanning electron microscopy study demonstrated that Fe3O4 nanofillers covered the cellulose matrix. The drug release from MC/5-FU was evaluated under various pH and temperature conditions, showing the maximum release at pH 7.4 and 44.2 degrees C. In in vitro anticancer assay, MC/5-FU exhibited enhanced selectivity and anticancer actions against 2D monolayer and 3D tumour spheroid models colorectal cancer cells. The anticancer effects of MC/5-FU with magnetic targeting and heat induction were also examined. This easily synthesized MC/5-FU indicated the potential in application as a low-cost drug formulation for colorectal cancer treatments.
引用
收藏
页数:15
相关论文
共 50 条
  • [32] The influence of gut microbiota dysbiosis to the efficacy of 5-Fluorouracil treatment on colorectal cancer
    Yuan, Lu
    Zhang, Siruo
    Li, Huan
    Yang, Fan
    Mushtaq, Noosheen
    Ullah, Shakir
    Shi, Yi
    An, Cuihong
    Xu, Jiru
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 108 : 184 - 193
  • [33] Beyond 5-fluorouracil monochemotherapy in colorectal cancer - It is time
    Satta, F
    Franchi, F
    JOURNAL OF CHEMOTHERAPY, 1997, 9 (06) : 431 - 435
  • [34] Bufalin and 5-fluorouracil synergistically induce apoptosis in colorectal cancer cells
    Dai, Xiao-Yu
    Zhou, Bao-Feng
    Xie, Yang-Yang
    Lou, Jie
    Li, Ke-Qiang
    ONCOLOGY LETTERS, 2018, 15 (05) : 8019 - 8026
  • [35] Antitumor activity of electrospun polylactide nanofibers loaded with 5-fluorouracil and oxaliplatin against colorectal cancer
    Zhang, Jiayu
    Wang, Xue
    Liu, Tongjun
    Liu, Shi
    Jing, Xiabin
    DRUG DELIVERY, 2016, 23 (03) : 794 - 800
  • [36] CDK inhibitor enhances the sensitivity to 5-fluorouracil in colorectal cancer cells
    Takagi, Koichi
    Sowa, Yoshihiro
    Cevik, Ozgur Muhammer
    Nakanishi, Ryoko
    Sakai, Toshiyuki
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2008, 32 (05) : 1105 - 1110
  • [37] MicroRNAs and drug resistance in colorectal cancer with special focus on 5-fluorouracil
    Fahima Danesh Pouya
    Maria Gazouli
    Yousef Rasmi
    Dimitra Ioanna Lampropoulou
    Mohadeseh Nemati
    Molecular Biology Reports, 2022, 49 : 5165 - 5178
  • [38] Pharmacogenomics of 5-fluorouracil in colorectal cancer: review and update
    Xie, Pan
    Mo, Jun-Luan
    Liu, Jin-Hong
    Li, Xi
    Tan, Li-Ming
    Zhang, Wei
    Zhou, Hong-Hao
    Liu, Zhao-Qian
    CELLULAR ONCOLOGY, 2020, 43 (06) : 989 - 1001
  • [39] Clinical Significance of 5-Fluorouracil Chemosensitivity Testing in Patients with Colorectal Cancer
    Ji, Woong Bae
    Um, Jun Won
    Ryu, Je Seock
    Hong, Kwang Dae
    Kim, Jung Sik
    Min, Byung Wook
    Joung, Sung Yeop
    Lee, Ju Han
    Kim, Young Sik
    ANTICANCER RESEARCH, 2017, 37 (05) : 2679 - 2682
  • [40] PHARMACOKINETICS OF 5-FLUOROURACIL IN COLORECTAL-CANCER PATIENTS RECEIVING INTERFERON
    PITTMAN, K
    PERREN, T
    WARD, U
    PRIMROSE, J
    SLEVIN, M
    PATEL, N
    SELBY, P
    ANNALS OF ONCOLOGY, 1993, 4 (06) : 515 - 516